Anticoagulants improve outcomes in cirrhosis-related portal vein thrombosis

Anticoagulant treatment safely and effectively led to partial or complete recanalization of the portal venous system in more than half of patients with cirrhosis, according to recently published study results.
“Portal vein thrombosis (PVT) is a frequent complication in patients with cirrhosis, although it may often remain asymptomatic, at least early after onset,” I. Pettinari, MD, PhD, from the University of Bologna in Italy, and colleagues wrote. “However, PVT is usually associated with some major clinical complications, including worsening of portal hypertension and liver

Source link

Related posts

Patients Care About the Clothes Doctors Wear


Association between body mass index and fatty liver risk: A dose-response analysis


Global Prevalence and Risk Factors of Gastro-oesophageal Reflux Disease (GORD): Systematic Review with Meta-analysis


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy